Deanna L Kelly, Pharm.D, BCPP
University of Maryland, College Park
2
2
2
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Mary Lee, MD
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
Stephen J Heishman, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Worked with same sponsors:
A. Eden Evins, MD, MPH
Massachusetts General Hospital
Shared therapeutic areas:
Worked with same sponsors:
Michael B Gill
Power Life Sciences Inc.
Shared therapeutic areas:
Sanjeev Pathak, MD
Alkermes, Inc.
Shared therapeutic areas:
Yair bAR-hAIM, PhD
Tel Aviv University
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Urielle Desalbres
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
Nobuhito Sanada
Otsuka Pharmaceutical Co., Ltd.
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
Effects of Smoking Cues on Tobacco Craving Responses and the Reinforcing Efficacy of Cigarettes in Smokers With and Without Schizophrenia
Oxytocin and Social Cognition in Schizophrenia
All 2 trials loaded